- Lois et règlements
- eservices
-
Media Center
Hotline for Health Services for Displaced Lebanese 1787Hotline for the Patient Admission to Hospitals 01/832700COVID-19 Vaccine Registration Form covax.moph.gov.lbMoPH Hotline 1214
Are you a new member? Sign up now
close
DEPAKINE - 200mg - 40
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| N03AG01 | B | Sodium Valproate - 200mg | 2977 | 25734 | DEPAKINE | 200mg | 40 | Tablet, enteric coated | Oral | Mersaco | Sanofi Aventis SA | Spain | 240,548 L.L | 23.08 | A1 | Sanofi Aventis | France | 2/5/2024 | 0 |